跳至主要内容
临床试验/ACTRN12614000510640
ACTRN12614000510640已完成2 期

The prediction and prevention of hypoglycaemia using insulin suspension in a randomised controlled trial with the use of continuous subcutaneous insulin infusion with real-time continuous glucose monitoring system and predictive low glucose suspend feature (CSII + RT-CGMS + PLGM) versus sensor augmented pump therapy with continuous subcutaneous insulin infusion only (CSII+ RT-CGMS) in children and adolescents with type 1 diabetes (T1D)

Professor Timothy Jones0 个研究点目标入组 169 人开始时间: 2014年5月13日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
169

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
8 Years 至 20 Years(—)
性别
All

入选标准

  • 1) Age: 8-20yrs at Princess Margaret Hospital, Perth and John Hunter Children's Hospital, Newcastle; Age 8-18yrs at Westmead Children's Hospital, Sydney, Women and Children's Hospital,Adelaide and RCH, Melbourne
  • 2) T1DM for >1 year
  • 3) On insulin pump therapy for >6 months
  • 4) HbA1c < 10.0%

排除标准

  • 1) Medical conditions predisposing to hypoglycaemia other than diabetes
  • 2) Oral glycaemic medications
  • 3) Inability or refusal to meet protocol requirements
  • 4 ) Pregnancy

研究者

发起方
Professor Timothy Jones

相似试验